DRUGS REPORTS

Drugs Off-Patent Reports
Drugs Off-Patent
Reports
ISSN 0793694X
Year of Expiration - 2002
Drug OFF
Generic Patent Patent Exclusivity Patent & Earliest 1999
Patent
Name Holder Expiry Expiry Exclusivit Generic 2001 1
Marketer
y
Trade Generic NAME Patent # DATE CODES DATE USD$ (Mil)
Celebrex Celecoxib Pharmacia
11/30/2015
5-760-068
Optiray
320
Optiray
350
Monopril /
Vasopril
(10.20mg)
Ioversol Mallinc 12/30/02
4-396-598
Ioversol Mallinc 12/30/02
4-396-598
Fosinopril
Na
BMS 12/4/02
4-337-201
12/24/02
{I-284}
I-284
U-19
U-299
12/24/02 1 507
2 600
[772] 4q
4/12/02 -- 04/12/02 340
255
M/D/YY -- 10/11/02 105
121
12/28/98 - 12/13/02 205
NCE
08/03/02 -
ODE
08/03/02 250
M/D/YY -- 12/30/02 168
M/D/YY -- 12/30/02 69
05/02/98 -
I-92
Axid Nizatidine Lilly 4/12/02
4-375-547
Suprax Cefixime AHP/ 10/11/02
Lederle 4-409-214
Effexor Venlafaxine
AHP/ 12/13/02
Wyeth 4-535-186
Ayerst
Cordarone Amio AHP/
darone Wyeth P
Ayerst
Relafen Nambutone Smith
Kline
Beecham
12/13/02
4-420-639
Trovafloxacin
TROVAN Pfizer -- 12/18/02 -
mesylate
NCE
Carvedilol Coreg SKB 3/5/02
4-503-067
12/04/02 202
M/D/YY -- 12/13/02 450
380
9/14/00 U-3
NCE
12/18/02 160
155
03/05/02 100
101
Midazolam VERSED
inj
4q
= Fourth Quarter 2000
Roche 6/20/00
4-280-957
4/15/02 PED 04/15/02 324
380
NA = Not Applicable ODE = Orphan Drug Exclusivity NS = New Strength
NCE = New Chemical Entity NE = New Active Salt or Ester NP= New Drug Product
NDF = New Dosage Form NC = New Combination 2001 1 USA + EU Sales
U = Code for Therapeutic Use still I = Code for specific Indication D = New Dosing Schedule
under Patent Protection
under Exclusivity Protection
Drugs Off-Patent Reports 13 Over USD$ 100 million